The company also has a broad pipeline of wholly owned and worldwide patented sdAbs in different stages of development, including SBT-101, a mono-specific anti-STAT3 sdAb, SBT-102, a mono-specific ...

9 Antibodies were purchased from Cell Signaling (Danvers, MA, US) (anti-phospho-Y705 STAT3, anti-STAT3, anti-phospho-44/42 MAP-kinase ERK1/2 (Thr202, Tyr204), anti-phospho-Ser 473 AKT, anti-ERK1/2 ...